|
Pembrolizumab & Enfortumab Vedotin (PEV) Clinical Trials
1 actively recruiting trial across 1 location
Also known as: PADCEV
Oklahoma City, Oklahoma1 trial
Circulating Tumor DNA Response In Urothelial Cancer
OU Health Stephenson Cancer Center
Phase 2
Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.
This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.